Bionano Genomics, Inc. (BNGO)

USD 0.21

(-0.47%)

Operating Expenses Summary of Bionano Genomics, Inc.

  • Bionano Genomics, Inc.'s latest annual operating expenses in 2023 was 148.99 Million USD , up 8.25% from previous year.
  • Bionano Genomics, Inc.'s latest quarterly operating expenses in 2024 Q2 was 22.86 Million USD , down -34.56% from previous quarter.
  • Bionano Genomics, Inc. reported a annual operating expenses of 137.64 Million USD in annual operating expenses 2022, up 69.98% from previous year.
  • Bionano Genomics, Inc. reported a annual operating expenses of 80.97 Million USD in annual operating expenses 2021, up 95.95% from previous year.
  • Bionano Genomics, Inc. reported a quarterly operating expenses of 29.95 Million USD for 2024 Q1, up 33.3% from previous quarter.
  • Bionano Genomics, Inc. reported a quarterly operating expenses of 38.68 Million USD for 2023 Q3, down -6.9% from previous quarter.

Annual Operating Expenses Chart of Bionano Genomics, Inc. (2023 - 2016)

Historical Annual Operating Expenses of Bionano Genomics, Inc. (2023 - 2016)

Year Operating Expenses Operating Expenses Growth
2023 148.99 Million USD 8.25%
2022 137.64 Million USD 69.98%
2021 80.97 Million USD 95.95%
2020 41.32 Million USD 41.35%
2019 29.23 Million USD 23.34%
2018 23.7 Million USD -9.14%
2017 26.08 Million USD 7.0%
2016 24.38 Million USD 0.0%

Peer Operating Expenses Comparison of Bionano Genomics, Inc.

Name Operating Expenses Operating Expenses Difference
Prenetics Global Limited 60.73 Million USD -145.31%
Star Equity Holdings, Inc. 16.27 Million USD -815.64%
CareDx, Inc 277.76 Million USD 46.361%
Exact Sciences Corporation 2.06 Billion USD 92.769%
Exagen Inc. 52.29 Million USD -184.92%
Inotiv, Inc. 246.9 Million USD 39.655%
Guardant Health, Inc. 901.62 Million USD 83.475%
Biodesix, Inc. 77.41 Million USD -92.45%
BioNexus Gene Lab Corp. 3.92 Million USD -3697.852%
Precipio, Inc. 13.63 Million USD -992.484%
iSpecimen Inc. 16.27 Million USD -815.344%
Natera, Inc. 938.98 Million USD 84.133%
Aspira Women's Health Inc. 24.11 Million USD -517.869%
Standard BioTools Inc. 113.48 Million USD -31.284%
23andMe Holding Co. 420.73 Million USD 64.587%
Castle Biosciences, Inc. 242.78 Million USD 38.631%
Personalis, Inc. 128.14 Million USD -16.27%
Aclaris Therapeutics, Inc. 110.52 Million USD -34.805%
Applied DNA Sciences, Inc. 16.48 Million USD -803.715%
OpGen, Inc. 30.65 Million USD -385.985%
T2 Biosystems, Inc. 41.49 Million USD -259.071%
Myriad Genetics, Inc. 600.1 Million USD 75.172%
ICON Public Limited Company 755.64 Million USD 80.283%
NeoGenomics, Inc. 341.25 Million USD 56.339%
Star Equity Holdings, Inc. 16.27 Million USD -815.64%
IDEXX Laboratories, Inc. 1.09 Billion USD 86.366%
RadNet, Inc. 268.87 Million USD 44.587%
MDxHealth SA 71.25 Million USD -109.095%
Psychemedics Corporation 11.33 Million USD -1214.567%
Illumina, Inc. 3.81 Billion USD 96.092%
Check-Cap Ltd. 19.28 Million USD -672.505%
Twist Bioscience Corporation 354.18 Million USD 57.933%
DarioHealth Corp. 62.17 Million USD -139.643%
Fulgent Genetics, Inc. 171.9 Million USD 13.329%
Sera Prognostics, Inc. 39.91 Million USD -273.257%
ENDRA Life Sciences Inc. 10.52 Million USD -1316.184%
OPKO Health, Inc. 574.68 Million USD 74.074%
Medpace Holdings, Inc. 187.68 Million USD 20.613%
Neogen Corporation 405.23 Million USD 63.233%
Intelligent Bio Solutions Inc. 11.7 Million USD -1172.487%
Prenetics Global Limited 60.73 Million USD -145.31%
Mainz Biomed B.V. 27.15 Million USD -448.689%
bioAffinity Technologies, Inc. 8.76 Million USD -1599.894%
Trinity Biotech plc 46.49 Million USD -220.45%
Neuronetics, Inc. 82.25 Million USD -81.127%
Sotera Health Company 300.46 Million USD 50.413%
bioAffinity Technologies, Inc. 8.76 Million USD -1599.894%